CompaniesNano24med

Nano24med

active

Tel-Aviv, Israel

Founded 2020

About

CD24-enriched exosomes

Areas of Focus

Categories

Drug Delivery & Formulation

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

90

By Phase

PHASE2: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT05947747Lead Sponsor

Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS

PHASE2Recruiting

90 participants

Started: Jul 4, 2023 · Completed: Dec 20, 2025

Locations (1)

Headquarters

Tel-Aviv, Israel

Map

Loading map...